Akebia Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 4 U.S.-traded ETFs. AKBA has around 1.5M shares in the U.S. ETF market. The largest ETF holder of AKBA is the Vanguard Total Stock Market ETF (VTI), with approximately 678.69K shares.
$8 billion flowed into U.S.-listed ETFs in the latest week.
Smart-beta ETFs will come with low fees.
The firm’s family of 32 Rob Arnott-linked ‘fundamental’ ETFs has reached $5 billion in AUM.
PowerShares exec discusses RAFI-based ETFs' original fee structure and plans to slash those costs, and recent performance turnarounds.
Examination of the funds' returns year-to-date through the end of the third quarter and through Oct. 10
But a new twist is coming. A trio of ETFs are launching Friday, each an offshoot of popular Standard & Poor's benchmarks. They'll use the same stocks as their traditional S&P benchmarks. However, the ETFs will weight names by revenue rather than market-cap sizes.
Fundamentally weighted ETFs showed mixed performance in 2007.